Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)

NCT00105469 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

743

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Conjunctivitis

Interventions

DRUG: AzaSite
DRUG: Tobramycin

Sponsor

Merck Sharp & Dohme LLC